| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 525 | - | 0 | 0 | 101 | 0 | 186 | - |
| Total Income - EUR | - | - | 525 | - | 0 | 0 | 101 | 0 | 186 | - |
| Total Expenses - EUR | - | - | 327 | - | 0 | 0 | 28 | 1.655 | 7.749 | - |
| Gross Profit/Loss - EUR | - | - | 198 | - | 0 | 0 | 73 | -1.655 | -7.563 | - |
| Net Profit/Loss - EUR | - | - | 182 | - | 0 | 0 | 71 | -1.655 | -7.565 | - |
| Employees | - | - | 0 | - | 0 | 0 | 0 | 1 | 1 | - |
Check the financial reports for the company - Aragen Biotech Group S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | - | - | 417 | - | 401 | 0 | 458 | 255 | 308 | - |
| Inventories | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | - | - | 0 | - | 0 | 0 | 5 | 48 | 57 | - |
| Cash | - | - | 417 | - | 401 | 0 | 453 | 207 | 251 | - |
| Shareholders Funds | - | - | 401 | - | 386 | 0 | 441 | -1.212 | -8.774 | - |
| Social Capital | - | - | 219 | - | 211 | 0 | 202 | 203 | 202 | - |
| Debts | - | - | 16 | - | 15 | 0 | 17 | 1.468 | 9.082 | - |
| Income in Advance | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Aragen Biotech Group S.r.l.